● Pharmacogenetics
-
ALDH Genetic Polymorphism
Iyi kit inoshandiswa in vitro qualitative yekuona ALDH2 gene G1510A polymorphism saiti mumunhu peripheral ropa genomic DNA.
-
Munhu CYP2C9 uye VKORC1 Gene Polymorphism
Kiti iyi inoshanda kune in vitro qualitative diagnosis yepolymorphism yeCYP2C9*3 (rs1057910, 1075A>C) uye VKORC1 (rs9923231, -1639G>A) mune genomic DNA yemasampuli eropa revanhu.
-
Munhu CYP2C19 Gene Polymorphism
Kiti iyi inoshandiswa pakuongorora in vitro qualitative yepolymorphism yeCYP2C19 genes CYP2C19*2 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C19>2 c68 inrs. genomic DNA yemasampuli eropa revanhu.
-
Human Leukocyte Antigen B27 Nucleic Acid
Iyi kit inoshandiswa pakuonekwa kwemhando yeDNA mumunhu leukocyte antigen subtypes HLA-B*2702, HLA-B*2704 uye HLA-B*2705.
-
MTHFR Gene Polymorphic Nucleic Acid
Iyi kit inoshandiswa kuona 2 mutation nzvimbo dzeMTHFR gene. Iyo kiti inoshandisa ropa remunhu rose seyedzo sampuli kuti ipe hunhu hwekuongorora mamiriro ekuchinja. Zvinogona kubatsira varapi kugadzira zvirongwa zvekurapa zvinoenderana nehunhu hwakasiyana kubva pachikamu chemolecular, kuitira kuti uve nechokwadi chehutano hwevarwere kusvika pamwero mukuru.
